Pharma News, 2020

MIT neuroscientists have discovered that an enzyme called HDAC1 is critical for repairing age-related DNA damage to genes involved in memory and other cognitive functions.

Some 108 million people in China’s northeast region are being plunged back under lockdown conditions as a new and growing cluster of infections causes a backslide in the nation’s return to normal.

(Reuters) - AstraZeneca Plc said it was in talks with governments around the world to strike coronovirus vaccine production deals similar to one it agreed with Britain over the weekend.

BEIJING/TEL AVIV (Reuters) - Teva Pharmaceutical said on Monday that China has given the go-ahead to its Austedo treatment for Huntington’s disease.

WASHINGTON (Reuters) - Authorities are not seeing spikes in coronavirus cases in places that are reopening but are seeing increases in some areas that remain closed, U.

New Rochelle, NY, May 15, 2020 -- Data collected over a 15-week period showed that using virtual care to manage diabetes patients in the hospital does not have a negative impact on their glycemic outc...

The FDA previously split the review of Blueprint Medicines’ kinase inhibitor Ayvakit into two parts.

With ample coronavirus tests and not enough sick people seeking them, the mayor of Los Angeles recently did something on a scale no other major U.

After posting positive late-stage results for its rare blood disease drug, Sanofi has been handed a priority review from the FDA for sutimlimab.

After getting the cold shoulder from regulators over its filing for CAR-T candidate ide-cel earlier this week, Bristol Myers Squibb at least has good news now for one of the products it acquired throu...

NantKwest announced plans for a Phase 2, randomized, open-label study to evaluate the efficacy and safety of their combination immunotherapy.

Privately-held biopharma Exvastat (Ireland) Ltd has won a 3.